BIO Comments on FDA voluntary labeling of GE salmon
January 26, 2016
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide input on the U.S. Food and Drug Administration’s (FDA) draft guidance for industry on voluntary labeling of food derived from genetically engineered and non-genetically engineered Atlantic salmon (Salmo salar). BIO is the world's largest biotechnology trade association, representing companies, academic institutions, state biotechnology centers and related organizations. BIO members use biotechnology at all stages of research and product development to further innovation in a variety of economic sectors including human health, agricultural production, food processing, industrial manufacturing, energy production and environmental management.
The tools of biotechnology, which include genetic engineering, are used by many BIO members to develop and produce a wide variety of food and feed products, additives, processing aids and related detection technologies. As a result, BIO has a strong interest in FDA’s consistently applying the appropriate laws, regulations, and scientific principles to its requirements for food labels and labeling.
Download Full Comments Below
On August 6, BIO submitted comments on the NMPA Draft Technical Guideline on Clinical Trials of Cellular Immunotherapy Products. In the comments, BIO thanks NMPA for the opportunity to submit comments but argues for a more robust commenting period…